Emergent Initiation of Dialysis is Related to an Increase in Both Mortality and Medical Costs
Authors
Affiliations
The number of patients with end-stage renal disease (ESRD) has been increasing, with dialysis treatment being a serious economic problem. To date, no report in Japan considered medical costs spent at the initiation of dialysis treatment, although some reports in other countries described high medical costs in the first year. This study focused on patient status at the time of initiation of dialysis and examined how it affects prognosis and the medical costs. As a result, all patients dying within 4 months experienced emergent dialysis initiation. Emergent dialysis initiation and high medical costs were risk factors for death within 2 years. High C-reactive protein levels and emergent dialysis initiation were associated with increasing medical costs. Acute kidney injury (AKI) contributed most to emergent dialysis initiation followed by stroke, diabetes, heart failure, and short-term care by nephrologists. Therefore, emergent dialysis initiation was a contributing factor to both death and increasing medical costs. To avoid the requirement for emergent dialysis initiation, patients with ESRD should be referred to nephrologists earlier. Furthermore, ESRD patients with clinical histories of AKI, stroke, diabetes, or heart failure should be observed carefully and provided pre-planned initiation of dialysis.
An updated systematic review of the risk factors for unplanned dialysis initiation.
Magadi W, Birnie K, Santhakumaran S, Caskey F, Ben-Shlomo Y Clin Kidney J. 2024; 17(12):sfae333.
PMID: 39669010 PMC: 11635165. DOI: 10.1093/ckj/sfae333.
Zhou Y, Wang X, Yuan H, Wu L, Zhang B, Chen X Sci Rep. 2023; 13(1):20752.
PMID: 38007545 PMC: 10676370. DOI: 10.1038/s41598-023-48125-1.
Lim J, Kim J, Jeon Y, Kim Y, Kang S, Yang C Sci Rep. 2023; 13(1):6049.
PMID: 37055558 PMC: 10102303. DOI: 10.1038/s41598-023-33216-w.
Fukuzaki H, Nakata J, Nojiri S, Shimizu Y, Shirotani Y, Maeda T Sci Rep. 2023; 13(1):5991.
PMID: 37045851 PMC: 10097859. DOI: 10.1038/s41598-023-31636-2.
Lima H, Nerbass F, Lugon J, Sesso R Int Urol Nephrol. 2023; 55(8):2025-2033.
PMID: 36809641 DOI: 10.1007/s11255-023-03489-1.